Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N924- Excessive bleeding in the premenopausal period Health Condition 3: N926- Irregular menstruation, unspecified Health Condition 4: N950- Postmenopausal bleeding
Conditions
Interventions
Intervention1: Pipelle endometrial sampling: Patient with abnormal uterine bleeding will be admitted and before getting induced under general anesthesia for hysteroscopic guided biopsy , pipelle endom
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: 1.Women with more than 40 years of age with symptoms suggestive of abnormal uterine bleeding . 2.In pre-menopausal women with endometrial thickness with 7 to 12 millimeters. 3.In post-menopausal women with endometrial thickness with more than 4 millimeters. 4. In post-menopausal women with endometrial thickness less than 4 millimeters endometrial sampling will be done if - a. If repeated bleeding after primary treatment. b. If endometrium shows diffuse /focal increase in echogenicity. c. If endometrium is not adequately visualized on sonography.
Exclusion criteria
Exclusion criteria: 1. Patient on contraceptives, anticoagulants , thrombolytics or any evidence of blood dyscrasia or coagulation defects, autoimmune illness or chronic illness. 2. Patient with thrombocytopenia ( less than 100000 platelet/mm3 ). 3.Patient with active genital infection . 4.Patient with focal lesions of cervix or endometrium .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the diagnostic accuracy of pipelle endometrial sampling versus hysteroscopic guided endometrial biopsy in patient with abnormal uterine bleeding with endometrial pathology which is based on - 1. Histopathological report obtained by the two sampling techniquesTimepoint: It will be analysed based on the histopathological report obtained by the two screening techniques which will be available in 1 week | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the pipelle endometrial sampling versus hysteroscopic guided endometrial biopsy as two screening modalities in terms of 1.Comparing the associated complications in both the techniques . 2. Comparing the patient compliance in both the procedure. 3. comparing the time duration & post procedure complications.Timepoint: It will be analysed by the subjective experience of the patient regarding the compliance & post procedure complications including anesthesia related & procedural during the immediate post operative period & subsequent follow up at 1 week with histopathological report | — |
Countries
India
Contacts
Public ContactDr. Lajja Devi Goyal
AIIMS BATHINDA
Outcome results
None listed